Related Experiment Video
Updated: Feb 1, 2026

Pressure Controlled Ventilation to Induce Acute Lung Injury in Mice
Published on: May 5, 2011
Granisetron protects polymicrobial sepsis-induced acute lung injury in mice
Jun Wang1, Shenhai Gong2, Fangzhao Wang2
1Department of Respiration, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Pathophysiology, Guangdong Provincial Key Laboratory of Proteomics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China; State Key Laboratory of Organ Failure Research, Southern Medical University, Guangzhou, China.
Abstract:
Sepsis is a serious condition with a high mortality rate worldwide. Granisetron is an anti-nausea drug for patients undergoing chemotherapy. Here we aimed to identify the novel effect of granisetron on sepsis-induced acute lung injury (ALI). Our results showed that mice treated with granisetron displayed less severe lung damage than controls. Granisetron administration reduced pulmonary neutrophil recruitment after CLP. Moreover, the expressions of Cxcl1 and Cxcl2 were diminished in the presence of granisetron in THP-1 macrophages after lipopolysaccharide exposure. Additionally, granisetron could inhibit the activation of p38 MAPK and NLRP3 inflammasome both in vivo and in vitro. Collectively, granisetron protects against sepsis-induced ALI by suppressing macrophage Cxcl1/Cxcl2 expression and neutrophil recruitment in the lung.
Insights
Granisetron, an anti-nausea drug, shows promise in treating sepsis-induced acute lung injury (ALI). It reduces lung damage and inflammation by inhibiting key inflammatory pathways.
Area of Science:
- Immunology
- Pharmacology
- Critical Care Medicine
Background:
- Sepsis is a life-threatening condition with significant global mortality.
- Sepsis-induced acute lung injury (ALI) is a severe complication.
- Granisetron is primarily used as an anti-nausea medication.
Purpose of the Study:
- To investigate the potential therapeutic effects of granisetron on sepsis-induced ALI.
- To elucidate the underlying mechanisms by which granisetron may impact ALI.
Main Methods:
- Animal models of sepsis-induced ALI were treated with granisetron.
- Macrophage cell lines (THP-1) were stimulated with lipopolysaccharide (LPS) in vitro.
- Pulmonary neutrophil recruitment, chemokine expression (Cxcl1, Cxcl2), and inflammatory signaling pathways (p38 MAPK, NLRP3 inflammasome) were assessed.
Main Results:
- Granisetron treatment significantly reduced lung damage in mice with sepsis-induced ALI.
- Administration of granisetron decreased neutrophil infiltration in the lungs.
- Granisetron suppressed Cxcl1 and Cxcl2 expression in macrophages and inhibited p38 MAPK and NLRP3 inflammasome activation.
Conclusions:
- Granisetron demonstrates a protective effect against sepsis-induced ALI.
- The mechanism involves the suppression of macrophage chemokine production (Cxcl1/Cxcl2) and reduced neutrophil recruitment.
- Granisetron's anti-inflammatory properties extend beyond its anti-nausea effects, offering potential for ALI treatment.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

